Promising results from a small clinical trial highlight a growing interest in designing gene-editing treatments for common ...
The real revolution came in 2012, when researchers Jennifer Doudna and Emmanuelle Charpentier harnessed CRISPR, a natural bacterial defense system. In bacteria, CRISPR cuts out invading viruses’ DNA ...
An experimental gene-editing treatment shows promise for permanently lowering levels of cholesterol and triglycerides, ...
An experimental gene-editing therapy developed by Crispr Therapeutics is showing promise for treating heart disease.
Investor's Business Daily on MSN
Why Gene-Editing Giants Crispr Therapeutics And Intellia Therapeutics Diverged
Crispr stock reversed lower Monday, while Intellia stock surged, on promising updates for their gene-editing efforts.
Explore CRISPR technology explained, gene editing science, DNA modification, and genetic engineering ethics—discover how ...
By reactivating a long-lost gene, researchers were able to lower uric acid levels and stop damaging fat accumulation in human ...
The approach is “very exciting,” but one expert says a lot more research is needed, especially around safety, before clinical ...
The FDA’s Marty Makary and Vinay Prasad have laid out a path for CRISPR treatments on demand. An expert weighs in on what it ...
One dose of an experimental drug cover offer lifetime treatment for people with high cholesterol, but its long-term safety is ...
In a world first, a bespoke gene-editing therapy benefited one child. Now researchers plan to launch a clinical trial of the ...
CRISPR is a gene-editing tool that acts like “molecular scissors,” but using it on cancer is complex. The technology’s biggest impact so far is in research labs, helping scientists understand how ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results